Literature DB >> 25027110

Bone status and fractures in 85 adults with Wilson's disease.

A-S Quemeneur1, J-M Trocello, H-K Ea, A Ostertag, A Leyendecker, J-C Duclos-Vallée, M-C de Vernejoul, F Woimant, F Lioté.   

Abstract

UNLABELLED: Wilson's disease is characterized by copper deposition, especially in the liver and central nervous system. We assessed the prevalent fractures and bone mineral density (BMD) and related risk factors in 85 patients. BMD was normal, but patients with severe neurological involvement, low BMI, and/or amenorrhea are at risk for fractures.
INTRODUCTION: Wilson's disease (WD) is characterized by copper deposition, especially in the liver and central nervous system. Two studies showed a high prevalence of osteoporosis in WD patients. We wanted to assess the prevalent fractures and bone mineral density (BMD) and to identify risk factors for bone loss and fractures in a large group of WD patients.
METHODS: In this prospective cross-sectional survey at National center of reference for WD, we included 85 patients, 47 women, and 38 men, with a mean age of 35 ± 10 years, and mean time from diagnosis to study of 21 ± 9 years; 57 (67%) patients had neurological signs. Peripheral fractures, prevalent radiological vertebral fractures (VFx), and dual-energy X-ray absorptiometry BMD measurements at the femoral neck (FN) and lumbar spine (LS) were studied.
RESULTS: Mean LS and FN Z-score was normal (-0.37 ± 1.20 at LS and -0.06 ± 1.20 at FN). BMI <19 kg/m(2) and amenorrhea were associated with low BMD. Prevalent peripheral fractures were noted in 43 (51%) and VF in 7 (8%) patients. Severity of neurological involvement and male sex was associated with peripheral fractures, whereas older age, severe neurological involvement, and low BMD and Z-score values were associated with VF.
CONCLUSION: Our data showing normal BMD overall do not support routine bone status evaluation in adults with WD. However, patients with severe neurological involvement, low BMI, and/or amenorrhea are at risk factors for fractures and may require specific monitoring.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027110     DOI: 10.1007/s00198-014-2806-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  39 in total

1.  Proceedings: The musculoskeletal features of Wilson's disease: a clinical, radiological, and serological survey.

Authors:  D N Golding; J M Walshe
Journal:  Ann Rheum Dis       Date:  1975-04       Impact factor: 19.103

Review 2.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

3.  Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease.

Authors:  D Hegedus; V Ferencz; P L Lakatos; S Meszaros; P Lakatos; C Horvath; F Szalay
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

4.  [Joint involvement in Wilson's disease].

Authors:  L Zakraoui; N Amara; M Hamza; A Mrabet; M Hamza; A Hila; S Haddad
Journal:  Rev Rhum Mal Osteoartic       Date:  1986-05

5.  Osteoarthropathy of hepatolenticular degeneration.

Authors:  H M Canelas; N Carvalho; M Scaff; A Vitule; E R Barbosa; E M Azevedo
Journal:  Acta Neurol Scand       Date:  1978-06       Impact factor: 3.209

6.  The histological effects of copper and zinc on chick embryo skeletal tissues in organ culture.

Authors:  J R Rest
Journal:  Br J Nutr       Date:  1976-09       Impact factor: 3.718

7.  Bone mineral density of children with Wilson disease: efficacy of penicillamine and zinc therapy.

Authors:  Mukadder Ayse Selimoglu; Vildan Ertekin; Hakan Doneray; Mustafa Yildirim
Journal:  J Clin Gastroenterol       Date:  2008-02       Impact factor: 3.062

8.  Radiologic study of 42 cases of Wilson disease.

Authors:  Y Z Xie; X Z Zhang; X H Xu; Z X Zhang; Y K Feng
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

9.  Subchondral cyst of the tibia secondary to Wilson disease.

Authors:  Masashi Kataoka; Hiroshi Tsumura; Ichiro Itonaga; Nobuhiro Kaku; Takehiko Torisu
Journal:  Clin Rheumatol       Date:  2004-05-15       Impact factor: 2.980

10.  Wilson's disease in a patient presenting with skeletal abnormalities.

Authors:  H Y Pan; C Y Huang; C L Lai
Journal:  Orthopedics       Date:  1985-06       Impact factor: 1.390

View more
  8 in total

1.  Bone demineralisation in a large cohort of Wilson disease patients.

Authors:  Karl Heinz Weiss; Mart Van de Moortele; Daniel Nils Gotthardt; Jan Pfeiffenberger; Jessica Seessle; Elena Ullrich; Evelien Gielen; Herman Borghs; Els Adriaens; Wolfgang Stremmel; Wouter Meersseman; Steven Boonen; David Cassiman
Journal:  J Inherit Metab Dis       Date:  2015-02-07       Impact factor: 4.982

Review 2.  Clinical manifestations of Wilson disease in organs other than the liver and brain.

Authors:  Karolina Dzieżyc-Jaworska; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Epidemiology, diagnosis, and treatment of Wilson's disease.

Authors:  Jing Liu; Jing Luan; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2017-11

4.  Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis.

Authors:  J Chenbhanich; C Thongprayoon; A Atsawarungruangkit; T Phupitakphol; W Cheungpasitporn
Journal:  Osteoporos Int       Date:  2017-11-06       Impact factor: 4.507

5.  Pathological Fracture of Femoral Neck Leading to a Diagnosis of Wilson's Disease: A Case Report and Review of Literature.

Authors:  Nishit Bhatnagar; Purushotham Lingaiah; Jeetendra Singh Lodhi; Yugal Karkhur
Journal:  J Bone Metab       Date:  2017-05-31

Review 6.  Bone health in patients with inborn errors of metabolism.

Authors:  M Langeveld; C E M Hollak
Journal:  Rev Endocr Metab Disord       Date:  2018-03       Impact factor: 6.514

7.  Serum copper levels are associated with bone mineral density and total fracture.

Authors:  Xinhua Qu; Zihao He; Han Qiao; Zanjing Zhai; Zhenyang Mao; Zhifeng Yu; Kerong Dai
Journal:  J Orthop Translat       Date:  2018-05-31       Impact factor: 5.191

Review 8.  An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.

Authors:  Young Joo Yang; Dong Joon Kim
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.